Drugs / Oleylphosphocholine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06124144 | Jun 2023 → Feb 2024 | leishmaniasis | University Hospital Tuebingen | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oleylphosphocholine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06124144 ↗ |
| Modality | Small molecule | — CHEMBL466042 ↗ |
| Route | Oral | “orally as a single dose” NCT06124144 ↗ |